Hudson Bay Capital Management LP Seres Therapeutics, Inc. Transaction History

Hudson Bay Capital Management LP

$16.3 Billion
Q1 2024

A detailed history of Hudson Bay Capital Management LP transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 5,425,000 shares of MCRB stock, worth $3.91 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

5,425,000

Previous 4,320,400 25.57%

Holding current value

$3.91 Million

Previous $6.05 Million 30.94%

% of portfolio

0.03%

Previous 0.04%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.75 - $1.56 $828,450 - $1.72 Million	1,104,600 Added 25.57%	5,425,000 $4.18 Million
Q4 2023 Feb 14, 2024	BUY	$0.93 - $2.15 $2.16 Million - $4.99 Million	2,320,600 Added 116.04%	4,320,400 $6.05 Million
Q3 2023 Nov 14, 2023	BUY	$2.33 - $5.07 $2.61 Million - $5.68 Million	1,119,800 Added 127.25%	1,999,800 $4.76 Million
Q2 2023 Aug 14, 2023	BUY	$4.67 - $6.55 $1.66 Million - $2.33 Million	355,000 Added 67.62%	880,000 $4.22 Million
Q1 2023 May 16, 2023	BUY	$4.95 - $6.09 $1.04 Million - $1.27 Million	209,229 Added 66.26%	525,000 $2.98 Million

Q1 2023 May 15, 2023	SELL	$4.95 - $6.09 $1.31 Million - $1.61 Million	-264,229 Reduced 45.56%	315,771 $1.79 Million
Q4 2022 Feb 14, 2023	BUY	$5.09 - $9.05 $1.09 Million - $1.95 Million	215,100 Added 58.95%	580,000 $3.25 Million
Q3 2022 Nov 14, 2022	SELL	$3.5 - $7.2 $1.25 Million - $2.57 Million	-357,200 Reduced 49.47%	364,900 $2.34 Million
Q2 2022 Aug 12, 2022	BUY	$2.7 - $7.62 $1.54 Million - $4.36 Million	572,100 Added 381.4%	722,100 $2.48 Million
Q1 2022 May 16, 2022	BUY	$6.3 - $8.84 $315,000 - $442,000	50,000 Added 50.0%	150,000 $1.07 Million
Q4 2021 Feb 14, 2022	SELL	$6.02 - $11.43 $2.23 Million - $4.23 Million	-370,000 Reduced 78.72%	100,000 $833,000
Q3 2021 Nov 15, 2021	BUY	$5.46 - $22.6 $2.57 Million - $10.6 Million	470,000 New	470,000 $3.27 Million

Others Institutions Holding MCRB

# of Institutions

100

Shares Held

62.7M

Call Options Held

36.9K

Put Options Held

476K

View Full List

About Seres Therapeutics, Inc.

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $89.3M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

More about MCRB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.

Account

Hudson Bay Capital Management LP Seres Therapeutics, Inc. Transaction History